第一单位：
Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Capital Region of Denmark, Denmark.
作者：
Karsten,Nysom [1]
;
Lindsay B,Kilburn [2]
;
Sarah E S,Leary [3]
;
Daniel B,Landi [4]
;
Evelien,de Vos-Kerkhof [5]
;
Sébastien,Perreault [6]
;
Olaf,Witt [7]
;
David S,Ziegler [8]
;
Pablo,Hernáiz Driever [9]
;
Andrea T,Franson [10]
;
Patricia A,Baxter [11]
;
Nicholas S,Whipple [12]
;
Cassie,Kline [13]
;
Devorah,Segal [14]
;
Nada,Jabado [15]
;
Simon,Bailey [16]
;
Geoffrey,McCowage [17]
;
Jordan R,Hansford [18]
;
Dong-Anh,Khuong-Quang [19]
;
Nicholas G,Gottardo [20]
;
Timothy,Hassall [21]
;
Jung Woo,Han [22]
;
Michal,Yalon Oren [23]
;
Susan N,Chi [24]
;
Jiaheng,Qiu [25]
;
Daniel,Da Costa [25]
;
Sandya,Govinda Raju [25]
;
Peter,Manley [25]
;
Darren,Hargrave [26]
作者单位：
Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Capital Region of Denmark, Denmark.
[1]
Children's National Hospital, Washington, District of Columbia, USA.
[2]
Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, Washington, USA.
[3]
Department of Pediatrics, Duke University, Durham, North Carolina, USA.
[4]
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
[5]
CHU Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
[6]
National Center for Tumor Diseases (NCT), Heidelberg, Germany.;German Cancer Consortium (DKTK), Heidelberg, Germany.;Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.;Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
[7]
School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.;Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia.;Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.
[8]
Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Berlin, German HIT-LOGGIC-Registry for LGG in Children and Adolescents, Pediatric Neurooncology Program, Berlin, Germany.
[9]
Department of Pediatrics, C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, Michigan, USA.
[10]
Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
[11]
Primary Children's Hospital and University of Utah, Salt Lake City, Utah, USA.
[12]
Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
[13]
NYU Langone Health, New York, New York, USA.
[14]
Department of Pediatrics, McGill University Health Centre (MUHC), The Montreal Children's Hospital (MCH), Montréal, Quebec, Canada.
[15]
Great North Children's Hospital and Newcastle University Centre for Cancer, Newcastle-upon-Tyne, UK.
[16]
Sydney Children's Hospitals Network, Westmead, New South Wales, Australia.
[17]
South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.;South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.;Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital, Adelaide, South Australia, Australia.
[18]
Children's Cancer Centre, The Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
[19]
Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Washington, Australia.;Department of Pediatric and Adolescent Oncology and Hematology, Perth Children's Hospital, Perth, Western Australia, Australia.
[20]
Children's Health Queensland Hospital and Health Service, South Brisbane, Australia.
[21]
Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea.
[22]
Pediatric Hemato-Oncology Department, Sheba Medical Center, Ramat Gan, Tel Aviv District, Israel.
[23]
Pediatric Neuro-Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
[24]
Day One Biopharmaceuticals, Brisbane, California, USA.
[25]
UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.
[26]
DOI
10.1093/neuonc/noae274
PMID
39700439
发布时间
2025-07-22
换一批
